{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:46:02Z","timestamp":1789501562780,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02248-4","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:08:08Z","timestamp":1774890488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Qirong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2248_CR1","unstructured":"World Obesity Federation. World Obesity Atlas 2021. World Obesity Federation; 2021."},{"issue":"10113","key":"2248_CR2","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"L Abarca-G\u00f3mez","year":"2017","unstructured":"Abarca-G\u00f3mez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390(10113):2627\u201342.","journal-title":"Lancet"},{"issue":"5","key":"2248_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","volume":"10","author":"H Jebeile","year":"2022","unstructured":"Jebeile H, Kelly AS, O\u2019Malley G, et al. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10(5):351\u201365.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2248_CR4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1515\/jpem-2020-0250","volume":"33","author":"KC Petri","year":"2020","unstructured":"Petri KC, Hale P, Hesse D, et al. Liraglutide pharmacokinetics and exposure-response in pediatric patients with type 2 diabetes. J Pediatr Endocrinol Metab. 2020;33(9):1147\u201354.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2248_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/obr.12334","volume":"17","author":"M Simmonds","year":"2016","unstructured":"Simmonds M, Llewellyn A, Owen CG, et al. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17(2):95\u2013107.","journal-title":"Obes Rev"},{"key":"2248_CR6","doi-asserted-by":"publisher","first-page":"e12799","DOI":"10.1111\/ijpo.12799","volume":"16","author":"adolescents with obesity","year":"2021","unstructured":"adolescents with obesity. Pediatr Obes. 2021;16:e12799.","journal-title":"Pediatr Obes"},{"issue":"10","key":"2248_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S2352-4642(22)00185-7","volume":"6","author":"J Reyes-Angel","year":"2022","unstructured":"Reyes-Angel J, Kaviany P, Rastogi D, et al. Obesity-related asthma in children and adolescents. Lancet Child Adolesc Health. 2022;6(10):713\u201324.","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"2248_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.gtc.2023.03.002","volume":"52","author":"N Alfaris","year":"2023","unstructured":"Alfaris N, Alqahtani AM, Alamuddin N, et al. Global Impact of Obesity. Gastroenterol Clin North Am. 2023;52(2):277\u201393.","journal-title":"Gastroenterol Clin North Am"},{"issue":"14","key":"2248_CR9","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3390\/nu14142993","volume":"14","author":"J Gong","year":"2022","unstructured":"Gong J, Shen Y, Zhang H, et al. Gut Microbiota Characteristics of People with Obesity by Meta-Analysis of Existing Datasets. Nutrients. 2022;14(14):2993.","journal-title":"Nutrients"},{"issue":"3","key":"2248_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMcp2102062","volume":"389","author":"S Tamara","year":"2023","unstructured":"Tamara S, Hannon TS, Arslanian SA. Obesity in Adolescents. N Engl J Med. 2023;389(3):251\u201361.","journal-title":"N Engl J Med"},{"key":"2248_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fendo.2020.00290","volume":"11","author":"KS Czepiel","year":"2020","unstructured":"Czepiel KS, Perez NP, Reyes KJC, et al. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US. Front Endocrinol (Lausanne). 2020;11:290.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2248_CR12","doi-asserted-by":"publisher","first-page":"e13642","DOI":"10.1111\/obr.13642","volume":"25","author":"LA Eggerichs","year":"2024","unstructured":"Eggerichs LA, Nagpal TS, Ramos Salas X, et al. Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation. Obes Rev. 2024;25(1):e13642.","journal-title":"Obes Rev"},{"issue":"Suppl 1","key":"2248_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/obr.12255","volume":"16","author":"PS MacLean","year":"2015","unstructured":"MacLean PS, Higgins JA, Giles ED, et al. The role for adipose tissue in weight regain after weight loss. Obes Rev. 2015;16(Suppl 1):45\u201354.","journal-title":"Obes Rev"},{"issue":"9","key":"2248_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41574-023-00858-9","volume":"19","author":"AS Kelly","year":"2023","unstructured":"Kelly AS. Current and future pharmacotherapies for obesity in children and adolescents. Nat Rev Endocrinol. 2023;19(9):534\u201341.","journal-title":"Nat Rev Endocrinol"},{"key":"2248_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). 2019;10:155.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2248_CR16","unstructured":"Food and Drug Administration. FDA Approves Weight Management Drug for Patients Aged 12 and Older. June 2021. Available from: https:\/\/www.fda.gov\/ [Accessed 19 June 2024]."},{"key":"2248_CR17","doi-asserted-by":"publisher","first-page":"204201882091878","DOI":"10.1177\/2042018820918789","volume":"11","author":"K Woodard","year":"2020","unstructured":"Woodard K, Louque L, Hsia DS. Medications for the treatment of obesity in adolescents. Ther Adv Endocrinol Metab. 2020;11:2042018820918789.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2248_CR18","unstructured":"European Medicines Agency. Wegovy: summary of product characteristics. July; 2022."},{"issue":"2","key":"2248_CR19","first-page":"208","volume":"10","author":"A Cornejo-Estrada","year":"2023","unstructured":"Cornejo-Estrada A, Nieto-Rodr\u00edguez C, Le\u00f3n-Figueroa DA. Efficacy of Liraglutide in Obesity in Children and Adolescents: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Child (Basel). 2023;10(2):208.","journal-title":"Child (Basel)"},{"issue":"1","key":"2248_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-023-00435-4","volume":"9","author":"NB Lister","year":"2023","unstructured":"Lister NB, Baur LA, Felix JF, et al. Child and adolescent obesity. Nat Rev Dis Primers. 2023;9(1):24.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2248_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ijo.2013.162","volume":"38","author":"J Van Can","year":"2014","unstructured":"Van Can J, Sloth B, Jensen CB, et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (Lond). 2014;38(6):784\u201393.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"2248_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242\u201351.","journal-title":"Diabetes Obes Metab"},{"key":"2248_CR23","unstructured":"Christou G, Katsiki N, Kiortsis D. The current role of liraglutide in the pharmacotherapy of obesity. Curr Vasc Pharmacol."},{"issue":"7","key":"2248_CR24","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"2248_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2248_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/clinem\/dgac549","volume":"108","author":"G Diene","year":"2023","unstructured":"Diene G, Angulo M, Hale PM, et al. Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity. J Clin Endocrinol Metab. 2023;108(1):4\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2248_CR27","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3892\/etm.2017.4129","volume":"13","author":"QX Zhou","year":"2017","unstructured":"Zhou QX, Wang ZY, Zhao HF, et al. The effects of GLP-1 analogues on pre-diabetes of the children. Exp Ther Med. 2017;13(4):1426\u201330.","journal-title":"Exp Ther Med"},{"issue":"5","key":"2248_CR28","doi-asserted-by":"publisher","first-page":"e12495","DOI":"10.1111\/ijpo.12495","volume":"14","author":"LD Mastrandrea","year":"2019","unstructured":"Mastrandrea LD, Witten L, Carlsson KC, et al. Liraglutide effects in a paediatric (7\u201311 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes. 2019;14(5):e12495.","journal-title":"Pediatr Obes"},{"issue":"7","key":"2248_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJMoa1903822","volume":"381","author":"WV Tamborlane","year":"2019","unstructured":"Tamborlane WV, Barrientos-P\u00e9rez M, Fainberg U, et al. Liraglutide in Children and Adolescents with Type 2 Diabetes. N Engl J Med. 2019;381(7):637\u201346.","journal-title":"N Engl J Med"},{"issue":"22","key":"2248_CR30","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","volume":"382","author":"AS Kelly","year":"2020","unstructured":"Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020;382(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"6","key":"2248_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa2407379","volume":"392","author":"CK Fox","year":"2025","unstructured":"Fox CK, Barrientos-P\u00e9rez M, Bomberg EM, et al. Liraglutide for Children 6 to <\u200912 Years of Age with Obesity-A Randomized Trial. N Engl J Med. 2025;392(6):555\u201365. [Note: Please confirm year].","journal-title":"N Engl J Med"},{"issue":"4","key":"2248_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamapediatrics.2013.1045","volume":"167","author":"AS Kelly","year":"2013","unstructured":"Kelly AS, Rudser KD, Brandon M, et al. The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled, Clinical Trial. JAMA Pediatr. 2013;167(4):355\u201360.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"2248_CR33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/oby.23395","volume":"30","author":"CK Fox","year":"2022","unstructured":"Fox CK, Clark JM, Rudser KD, et al. Exenatide for Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial. Obes (Silver Spring). 2022;30(5):1105\u201315.","journal-title":"Obes (Silver Spring)"},{"issue":"24","key":"2248_CR34","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","volume":"387","author":"D Weghuber","year":"2022","unstructured":"Weghuber D, Barrett T, Barrientos-P\u00e9rez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med. 2022;387(24):2245\u201357.","journal-title":"N Engl J Med"},{"issue":"8","key":"2248_CR35","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/oby.23808","volume":"31","author":"AS Kelly","year":"2023","unstructured":"Kelly AS, Arslanian S, Hesse D, et al. Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4\u00a0mg. Obes (Silver Spring). 2023;31(8):2139\u201349.","journal-title":"Obes (Silver Spring)"},{"issue":"7","key":"2248_CR36","doi-asserted-by":"publisher","first-page":"e12624","DOI":"10.1111\/ijpo.12624","volume":"15","author":"D Weghuber","year":"2020","unstructured":"Weghuber D, Forslund A, Ahlstr\u00f6m H, et al. A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity. Pediatr Obes. 2020;15(7):e12624.","journal-title":"Pediatr Obes"},{"key":"2248_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpeds.2016.10.076","volume":"181","author":"T Danne","year":"2017","unstructured":"Danne T, Biester T, Kapitzke K, et al. Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12\u201317 Years. J Pediatr. 2017;181:146\u2013e1533.","journal-title":"J Pediatr"},{"issue":"5","key":"2248_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa2204601","volume":"387","author":"SA Arslanian","year":"2022","unstructured":"Arslanian SA, Hannon T, Zeitler P, et al. Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes. N Engl J Med. 2022;387(5):433\u201343.","journal-title":"N Engl J Med"},{"issue":"8","key":"2248_CR39","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.2337\/dc21-2275","volume":"45","author":"WV Tamborlane","year":"2022","unstructured":"Tamborlane WV, Bishai R, Geller D, et al. Once-Weekly Exenatide in Youth With Type 2 Diabetes. Diabetes Care. 2022;45(8):1833\u201340.","journal-title":"Diabetes Care"},{"issue":"8","key":"2248_CR40","doi-asserted-by":"publisher","first-page":"e12778","DOI":"10.1111\/ijpo.12778","volume":"16","author":"MO Bensignor","year":"2021","unstructured":"Bensignor MO, Bomberg EM, Bramante CT, et al. Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial. Pediatr Obes. 2021;16(8):e12778.","journal-title":"Pediatr Obes"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02248-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:22:39Z","timestamp":1778455359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02248-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2248"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02248-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}